Olympian and melanoma survivor Cate Campbell, and Melanoma Institute Australia Co-Medical Directors Professor Georgina Long AO and Professor Richard Scolyer AO, will address the National Press Club of Australia.
Prof Long has been named No 1 Melanoma Expert in worldwide rankings just released by expertscape, based on articles published 2012-2022.
New clinical tool developed by Melanoma Institute Australia hailed a breakthrough in personalising treatment for all cancer patients.
An unprecedented number of breakthroughs to be presented by MIA researchers at world's leading clinical oncology conference.
Australian researchers and patients were critical to trialling this breakthrough new treatment for advanced melanoma patients.
Melanoma March 2022 is aiming to raise $1 million for a world-first clinical trial of a Personalised Immunotherapy Platform which could transform melanoma treatment.
A landmark report provides status of melanoma in Australia, and the the roadmap to achieve zero deaths from melanoma this decade.
In what is being hailed as one of the biggest breakthroughs in melanoma treatment since the advent of immunotherapy, a new study has revealed that drug treatment before surgery is effective in preventing deadly spread of the disease.
MIA has joined Sydney Health Partners, with a shared focus on more rapidly translating research evidence into patient benefit.
Cited an incredible 427 times around the world, showing its vital role in improving outcomes for people with advanced melanoma.
